Main menu

Discover nanopore sequencing

What can it do?
How does it work?
Our platform performance and accuracy

Explore products

Prepare Library prep and automation solutions
Sequence Flow cells and nanopore devices
Analyse Software and informatics tools

Research

Microbial genomics
Plant
Human genomics
Animal
Cancer research
Microbiome
Infectious disease
Population genomics
Clinical research
Environmental research & conservation

Techniques

Whole-genome sequencing
Epigenetics
Transcriptomics
SNVs and phasing
Multiomics
Assembly
Metagenomics
Fusion transcripts
Targeted sequencing
Gene expression
Single cell & spatial transcriptomics
Splice variation
Structural variation
Chromatin conformation

Focus areas

From portable to high-throughput benchtop devices, real-time nanopore sensing is a new generation of technology uncovering new biology across multiple sectors.

Biopharma Education Clinical

Resources

Documentation
Publications
Case studies
Videos
Posters
Brochures
White papers
Workflows
Getting started guides
Application notes
View all resources

Documentation

Find all the documentation needed for your nanopore experiments, including protocols and device manuals.

View all documentation

Nanopore Learning

Explore our online courses and video lessons to support your nanopore sequencing journey.

View Nanopore Learning

Company

About us
Board members
Executive team
Investor centre
Company history
Sustainability
Careers
Media resources

News & Events

News
Events
Blogs

Global partners

Channel partners
Sequencing service providers
Compatible products
For partners

Search Oxford Nanopore Technologies

Which site do you wish to search in?

ont_prod_en_v3

Select options from the list below

All

All

www

www

Store

Store

Resources

Resources

0 result available.

Search Oxford Nanopore Technologies

Select options from the list below

0 result available.

Home

News

Search

18 results

Select options from the list below

Sort by : Most Relevant

Sort by : Newest

Sort by : Oldest

Sort by : Recent Activity

0 result available.

Clinical research

Company news
Pioneering European collaboration to advance genetic diagnostics: introducing the European Long Read Innovation Network (ELRIN)
February 28 2025
Company news
Oxford Nanopore Technologies selected by Murdoch Children’s Research Institute to support landmark research into faster genetic screening for rare dis
August 9 2024
Company news
Oxford Nanopore Technologies collaborates with Twist Bioscience to launch Pharmacogenomics Beta Programme and advance personalised medicine
May 22 2024
Company news
Oxford Nanopore Technologies and UMC Utrecht collaborate on 1,000 human genome sequencing project
September 30 2024
Company news
Oxford Nanopore Technologies and Mahidol University launch first Centre of Excellence in Southeast Asia | Oxford Nanopore Technologies
November 28 2024
Company news
Oxford Nanopore Technologies and Dubai Health to collaborate on genetic screening
March 13 2025
Company news
Oxford Nanopore launches a 24-hour whole genome sequencing workflow for rare disease research
September 30 2025
Company news
Oxford Nanopore and UK Biobank to create world's first epigenetic dataset targeting the causes of cancer, dementia, complex disease | Oxford Nanopore Technologies
November 27 2024
Company news
Mayo Clinic and Oxford Nanopore announce collaboration to advance precision medicine for cancer and genetic disorders
October 19 2023
Company news
Interview: Parent-of-origin genome analysis presents the potential to improve future genetic testing
June 30 2023
Company news
Interview: Advancing long-read de novo genome assembly methods in clinical research
October 14 2022
Company news
Blog: Resolving structural variants causing antithrombin deficiency
September 14 2020
Company news
Blog: Copy number variation analysis from plasma: is it feasible using nanopore sequencing?
September 29 2020
Company news
bioMérieux makes strategic investment in Oxford Nanopore
October 19 2023
Company news
Breakthrough towards protein sequencing using Oxford Nanopore holds promise for disease research and drug development
September 12 2024
Company news
Bio-Techne and Oxford Nanopore expand agreement to accelerate development of genetics portfolio through 2032
October 9 2025
Company news
APAC Rare Disease Consortium launched to advance genomic innovation and rare disease diagnosis
February 27 2025
Company news
Al Jalila Children’s Hospital advances rare disease identification through Oxford Nanopore sequencing, a new study shows | Oxford Nanopore Technologies
November 14 2024

Filter

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers

© 2008 - 2025 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

Select Language

Select options from the list below

English

English

Español

Español

中文

中文

日本語

日本語

0 result available.